Holen Sie sich die Stockscreener-App
3.62
2.95%
-0.11
Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 5.485 | - | 1.986 |
| Operating Expenses |
8.88%
47.35
|
43.49 | 33.78 | 34.02 | 28.74 |
| Operating Income/Loss |
8.88%
-47.35
|
-43.49 | -28.30 | -34.02 | -26.75 |
| Nonoperating Income/Loss |
34.01%
0.71
|
1.076 | 0.449 | 1.291 | -0.129 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
9.97%
-46.64
|
-42.41 | -27.85 | -32.73 | -26.88 |
| Basic Average Shares |
0.66%
369.04
|
366.63 | - | 353.31 | 297.99 |
| Diluted Average Shares |
0.66%
369.04
|
366.63 | - | 353.31 | 297.99 |
| Basic Earnings Per Share |
8.33%
-0.13
|
-0.12 | - | -0.09 | -0.09 |
| Diluted Earnings Per Share |
8.33%
-0.13
|
-0.12 | - | -0.09 | -0.09 |
0.14%
13.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):